AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Biorestorative Therapies Inc.
/
2026-05-27
▲ SURGE
Biorestorative Therapies Inc.
+73.3%
BRTX
NASDAQ
Healthcare
2026-05-27
0.433
Close
0.25
Prev Close
+73.30%
Change
47.6x
Vol Ratio
Why It Surged
2026년 2월 10일, BioRestorative Therapies는 만성 요추 디스크 질환 치료제 BRTX-100의 임상 2상 시험 환자 등록 완료를 발표했다.
·
2026년 2월 10일, BioRestorative Therapies는 만성 요추 디스크 질환 치료제 BRTX-100의 임상 2상 시험 환자 등록 완료를 발표했다.
·
2026년 2월 12일, BioRestorative Therapies는 500만 달러 규모의 주식 공모(stock offering) 가격을 책정했다.
Related News
BioRestorative shares are trading lower. The company announced completion of patient enrollment in its Phase 2 clinical trial evaluating BRTX-100 for the treatment of chronic lumbar disc disease. - BioRestorative Therapies (NASDAQ:BRTX)
Benzinga
2026-02-10
BioRestorative prices $5M stock offering (BRTX:NASDAQ)
Seekingalpha
2026-02-12
NRx Pharmaceuticals, Inc. (NRXP) Stock Price, News, Quote & History
Ca.Finance.Yahoo
2026-03-07
United Therapeutics Authorized New Stock Repurchase Program Of Up To $2B - United Therapeutics (NASDAQ:UTHR)
Benzinga
2026-03-09
XORTX Therapeutics shares are trading higher after the company announced it delayed its 1-for-5 shares consolidation. - XORTX Therapeutics (NASDAQ:XRTX)
Benzinga
2026-03-26
Technical Analysis
Signals
BB Upper Break
Overbought
MACD Bullish
Above SMA20
Key Indicators
80.33
RSI (14)
0.22
SMA 20
0.11
Bollinger Lower
0.33
Bollinger Upper
0.22
Bollinger Mid
0.01
MACD
-0.01
MACD Signal
0.02
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Biorestorative Therapies Inc. Surged +73.3% on 2026-05-27 — Analysis | Alpha Lenz